Humira®

Humira is an anti-TNF monoclonal antibody that currently treats Crohn's disease, rheumatoid arthritis, ulcerative colitis, hidradenitis suppurativa, psoriasis, psoriatic arthritis, juvenile idiopathic arthritis, ankylosing spondylitis and uveitis.

Type of Molecule

Biologic

Target

TNF

Product Type

New Indication
Potential Indication Region Phase (1, 2, 3, Submitted, Approved)
Hidradenitis Suppurativa (HS) (US, EU) US, EU
Approved
Uveitis (US, EU, Japan) US, EU, JPN
Approved